Physician profile
Keith I Stokes
NPI 1821297961
$653,793.20
in general payments reported to CMS, 2019-2025
10 companies · $120K in 2025
The $120K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $67K · 2021: $85K · 2022: $104K · 2023: $120K · 2024: $114K · 2025: $120K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $353K · Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $353,000.00 |
| Food and Beverage | $653.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $353,000.00 | 2023-2025 | |
| Csl Behring | $299,000.00 | 2019-2022 | |
| Gilead Sciences, INC. | $797.39 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $397.42 | 2021-2025 | Pifeltro, Delstrigo, Capvaxive |
| Viiv Healthcare Company | $260.00 | 2021-2025 | Apretude, Cabenuva, Dovato |
| Janssen Products, Lp | $198.95 | 2021-2022 | |
| Janssen Biotech, INC. | $82.94 | 2021-2022 | |
| Theratechnologies INC. | $37.16 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.34 | 2024 | Spravato |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.